BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 16054426)

  • 21. Increased tissue inhibitor of metalloproteinase-1 expression and inhibition of gelatinase A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis.
    Chang YC; Yang SF; Tai KW; Chou MY; Hsieh YS
    Oral Oncol; 2002 Feb; 38(2):195-200. PubMed ID: 11854068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Areca nut-induced buccal mucosa fibroblast contraction and its signaling: a potential role in oral submucous fibrosis--a precancer condition.
    Chang MC; Lin LD; Wu HL; Ho YS; Hsien HC; Wang TM; Jeng PY; Cheng RH; Hahn LJ; Jeng JH
    Carcinogenesis; 2013 May; 34(5):1096-104. PubMed ID: 23349021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro production of interleukin-6 by human gingival, normal buccal mucosa, and oral submucous fibrosis fibroblasts treated with betel-nut alkaloids.
    Chen CC; Huang JF; Tsai CC
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 Nov; 11(11):604-14. PubMed ID: 7490793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arecoline stimulated early growth response-1 production in human buccal fibroblasts: suppression by epigallocatechin-3-gallate.
    Hsieh YP; Chen HM; Chang JZ; Chiang CP; Deng YT; Kuo MY
    Head Neck; 2015 Apr; 37(4):493-7. PubMed ID: 24436257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated vimentin expression in buccal mucosal fibroblasts by arecoline in vitro as a possible pathogenesis for oral submucous fibrosis.
    Chang YC; Tsai CH; Tai KW; Yang SH; Chou MY; Lii CK
    Oral Oncol; 2002 Jul; 38(5):425-30. PubMed ID: 12110335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunolocalization of cytokines and growth factors in oral submucous fibrosis.
    Haque MF; Harris M; Meghji S; Barrett AW
    Cytokine; 1998 Sep; 10(9):713-9. PubMed ID: 9770333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of arecoline on the differentiation of myofibroblasts of oral mucosa].
    Li X; Ling TY; Gao YJ
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Jul; 42(7):423-7. PubMed ID: 17961364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. STRO-1 confers myofibroblast transdifferentiation in fibroblasts derived from oral submucous fibrosis.
    Yu CC; Liao YW; Yu CH; Chang YC
    J Oral Pathol Med; 2018 Mar; 47(3):299-305. PubMed ID: 29210111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of protease-activated receptor-1 expression in human buccal fibroblasts stimulated with arecoline.
    Tsai CH; Lee SS; Huang FM; Chang YC
    Head Neck; 2013 Sep; 35(9):1314-8. PubMed ID: 22965839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevation of Twist expression by arecoline contributes to the pathogenesis of oral submucous fibrosis.
    Lee YH; Yang LC; Hu FW; Peng CY; Yu CH; Yu CC
    J Formos Med Assoc; 2016 May; 115(5):311-7. PubMed ID: 26088962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Research on inhibition of areca nut extract on human buccal keratinocytes].
    Feng Y; Ling T
    Hua Xi Kou Qiang Yi Xue Za Zhi; 1999 Aug; 17(3):233-5. PubMed ID: 12539292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression profiling of oral submucous fibrosis using oligonucleotide microarray.
    Hu Y; Jian X; Peng J; Jiang X; Li N; Zhou S
    Oncol Rep; 2008 Aug; 20(2):287-94. PubMed ID: 18636188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of HIF-1alpha in malignant transformation of oral submucous fibrosis.
    Tilakaratne WM; Iqbal Z; Teh MT; Ariyawardana A; Pitiyage G; Cruchley A; Stewart JE; Hagi-Pavli E; Lalli A; Waseem A; Parkinson EK; Fortune F
    J Oral Pathol Med; 2008 Jul; 37(6):372-7. PubMed ID: 18221327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arecoline-stimulated connective tissue growth factor production in human buccal mucosal fibroblasts: Modulation by curcumin.
    Deng YT; Chen HM; Cheng SJ; Chiang CP; Kuo MY
    Oral Oncol; 2009 Sep; 45(9):e99-e105. PubMed ID: 19457704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of collagen-related genes and susceptibility to betel quid-induced oral submucous fibrosis.
    Chiu CJ; Chang ML; Chiang CP; Hahn LJ; Hsieh LL; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):646-53. PubMed ID: 12101112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1.
    Chang YC; Tsai CH; Lai YL; Yu CC; Chi WY; Li JJ; Chang WW
    J Cell Mol Med; 2014 Apr; 18(4):698-708. PubMed ID: 24400868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of novel biomarkers in oral submucous fibrosis by microarray analysis.
    Li N; Jian X; Hu Y; Xu C; Yao Z; Zhong X
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2249-59. PubMed ID: 18768491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulation of matrix metalloproteinase-1 (MMP-1) expression in oral carcinomas of betel quid (BQ) users: roles of BQ ingredients in the acceleration of tumour cell motility through MMP-1.
    Lee CH; Liu SY; Lin MH; Chiang WF; Chen TC; Huang WT; Chou DS; Chiu CT; Liu YC
    Arch Oral Biol; 2008 Sep; 53(9):810-8. PubMed ID: 18571622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNF-alpha production of oral epithelial cells by areca nut extract and arecoline.
    Jeng JH; Wang YJ; Chiang BL; Lee PH; Chan CP; Ho YS; Wang TM; Lee JJ; Hahn LJ; Chang MC
    Carcinogenesis; 2003 Aug; 24(8):1301-15. PubMed ID: 12807728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of IGF-2 and IGF-1 receptor expression in oral cancer cell lines.
    Brady G; Crean SJ; Naik P; Kapas S
    Int J Oncol; 2007 Oct; 31(4):875-81. PubMed ID: 17786320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.